Company Overview
I will be brief in the company overview since you can get a much more detailed breakdown of Athersys (ATHX) research strategy at their website, but they are developing drugs to treat various conditions that have little or no other treatment alternatives by using their proprietary stem cell product, MultiStem, a regenerative medicine. They have various trials underway to treat neurological, inflammatory and immune, and cardiovascular diseases and conditions, which I will discuss later in this article, using MultiStem. They are partnered with Helios, a Japanese company, which is running